Related Experiment Video
Updated: Jan 20, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer
Yohei Sekino1, Xiangrui Han2, Takafumi Kawaguchi2
1Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan. akikosekino@gmail.com.
Abstract:
Recent studies have reported that TUBB3 overexpression is involved in docetaxel (DTX) resistance in prostate cancer (PCa). The aim of this study was to clarify the role of TUBB3 in DTX and cabazitaxel (CBZ) resistance, and cross-resistance between DTX and CBZ in PCa. We analyzed the effect of TUBB3 knockdown on DTX and CBZ resistance and examined the interaction between TUBB3 and PTEN. We also investigated the role of phosphoinositide 3-kinases (PI3K) inhibitor (LY294002) in DTX and CBZ resistance. TUBB3 expression was upregulated in DTX-resistant and CBZ-resistant cells. TUBB3 knockdown re-sensitized DTX-resistant cells to DTX and CBZ-resistant cells to CBZ. Additionally, TUBB3 knockdown re-sensitized DTX-resistant cell lines to CBZ, indicating that TUBB3 mediates cross-resistance between DTX and CBZ. Knockdown of TUBB3 enhanced PTEN expression, and PTEN knockout enhanced TUBB3 expression. LY294002 suppressed TUBB3 expression in DTX-resistant and CBZ-resistant cell lines. LY294002 re-sensitized DTX-resistant cell lines to DTX and CBZ-resistant cell lines to CBZ. These results suggest that TUBB3 is involved in DTX resistance and CBZ resistance. A combination of LY294002/DTX and that of LY294002/CBZ could be potential strategies for PCa treatment.
Insights
Tubulin beta 3 (TUBB3) overexpression drives docetaxel and cabazitaxel resistance in prostate cancer. Reducing TUBB3 re-sensitizes cells to these treatments, suggesting combination therapies for improved outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Prostate cancer (PCa) often develops resistance to chemotherapy, including docetaxel (DTX) and cabazitaxel (CBZ).
- Overexpression of Tubulin beta 3 (TUBB3) has been implicated in DTX resistance in PCa.
- The precise role of TUBB3 in resistance to both DTX and CBZ, and the cross-resistance phenomenon, requires further elucidation.
Purpose of the Study:
- To investigate the role of TUBB3 in DTX and CBZ resistance in PCa.
- To determine if TUBB3 mediates cross-resistance between DTX and CBZ.
- To explore the interplay between TUBB3, PTEN, and the phosphoinositide 3-kinases (PI3K) pathway in chemoresistance.
Main Methods:
- TUBB3 knockdown was performed to assess its impact on DTX and CBZ resistance.
- Interactions between TUBB3 and PTEN were examined.
- The effect of a PI3K inhibitor (LY294002) on TUBB3 expression and chemoresistance was investigated.
Main Results:
- TUBB3 expression was elevated in both DTX-resistant and CBZ-resistant PCa cells.
- TUBB3 knockdown restored sensitivity to DTX and CBZ, and also re-sensitized cells to the alternative drug, indicating TUBB3 mediates cross-resistance.
- Knockdown of TUBB3 increased PTEN expression, while PTEN knockout increased TUBB3 expression. LY294002 inhibited TUBB3 expression and re-sensitized resistant cells to both DTX and CBZ.
Conclusions:
- TUBB3 is a key mediator of both DTX and CBZ resistance in prostate cancer.
- The PI3K pathway, influenced by PTEN, plays a role in regulating TUBB3 expression and chemoresistance.
- Combining LY294002 with DTX or CBZ presents a promising therapeutic strategy for overcoming chemoresistance in PCa.
Related Concept Videos
Treatment Resistant Cancers
Resistivity
Resistance
Diode: Reverse bias
Reversible and Irreversible Processes
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...

